Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation.

Abstract

The long-term biochemical and clinical effectiveness of allogenic bone marrow transplantation (BMT) was shown in a severely affected, transfusion-dependent 18-month-old female with congenital erythropoietic porphyria (CEP), an autosomal recessive inborn error of heme biosynthesis resulting from mutations in the uroporphyrinogen III synthase (URO-synthase… (More)

5 Figures and Tables

Topics

  • Presentations referencing similar topics